Aminu Kano Teaching Hospital is a Federal Government Teaching Hospital located in Kano State, Nigeria. It was formerly known as Bayero University Teaching hospital. The current chief medical director is Abdurahaman Abba Shehe.

During the past decade, Aminu Kano Teaching Hospital conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aminu Kano Teaching Hospital" #1 sponsor was "Vanderbilt University Medical Center" with 9 trials, followed by "Global Blood Therapeutics" with 3 trials sponsored, "Bayero University Kano, Nigeria" with 2 trials sponsored, "RAND" with 2 trials sponsored and "Aminu Kano Teaching Hospital" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aminu Kano Teaching Hospital" #1 collaborator was "Aminu Kano Teaching Hospital" with 9 trials as a collaborator, "Murtala Muhammed Specialist Hospital" with 3 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator, "National Institutes of Health (NIH)" with 2 trials as a collaborator and "Ahmadu Bello University Teaching Hospital" with 1 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Aminu Kano Teaching Hospital" are "Sickle Cell Disease" (9 trials), "Sickle Cell Anemia" (5 trials), "Stroke" (5 trials), "Acute Appendicitis" (1 trials) and "Albuminuria" (1 trials). Many other conditions were trialed in "Aminu Kano Teaching Hospital" in a lesser frequency.

Most popular intervention types in "Aminu Kano Teaching Hospital" are "Drug" (12 trials), "Other" (10 trials), "Behavioral" (2 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Hydroxyurea" (2 trials), "Artificial Intelligence enabled electrocardiogram (AI-ECG)" (1 trials), "CPAP helmet" (1 trials) and "Circuit training exercise" (1 trials). Other intervention names were less common.

The vast majority of trials in "Aminu Kano Teaching Hospital" are 19 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Aminu Kano Teaching Hospital". 2 are not yet recruiting, 5 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Aminu Kano Teaching Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Aminu Kano Teaching Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 9 trials that are defined as “Not Applicable".